Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
BeOne Medicines
MOMA Therapeutics
Astellas Pharma Inc
Kestrel Therapeutics, Inc.
Institut Claudius Regaud
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Plexium, Inc.
Eilean Therapeutics
Deciphera Pharmaceuticals, LLC
Revolution Medicines, Inc.
St. Justine's Hospital
M.D. Anderson Cancer Center
USWM, LLC (dba US WorldMeds)
ARTBIO Inc.
Coherus Oncology, Inc.
Suzhou Abogen Biosciences Co., Ltd.
Conjupro Biotherapeutics, Inc.
Modulation Therapeutics, Inc.
Alterome Therapeutics, Inc.
First Hospital of China Medical University
IDEAYA Biosciences
National Institutes of Health Clinical Center (CC)
ImmunityBio, Inc.
Pfizer
Dana-Farber Cancer Institute
Eli Lilly and Company